Modification of opioid receptor activity by acid phosphatase in neuroblastoma x glioma NG108-15 hybrid cells.
Opioid receptor activity in neuroblastoma x glioma NG108-15 hybrid cell membranes was attenuated by acid phosphatase purified by high performance liquid chromatography and devoid of protease activity. Treatment of membranes with this phosphatase decreased opioid inhibition of adenylate cyclase and this effect was potentiated by the presence of the opioid agonist during the phosphatase treatment. Phosphatase treatment did not affect the number of opioid receptors but it did alter the distribution of receptors among affinity states, by increasing the percentage of receptors in the low affinity state. The similarities between these effects and desensitization of the opioid receptor, during chronic opioid treatment, are discussed.
Louie
A K
AK
Department of Pharmacology, University of California, San Francisco 94143.
Zhan
J N
JN
Law
P Y
PY
Loh
H H
HH
D000135:Acid Phosphatase / Q000378:metabolism*; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D000242:Cyclic AMP / Q000378:metabolism; D004174:Diprenorphine / Q000378:metabolism; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000378:metabolism; D016308:Enkephalin, Leucine-2-Alanine; D005048:Etorphine / Q000494:pharmacology; D005910:Glioma; D016316:Guanfacine; D006146:Guanidines / Q000494:pharmacology; D006822:Hybrid Cells / Q000378:metabolism*; D009447:Neuroblastoma; D010648:Phenylacetates / Q000494:pharmacology; D011957:Receptors, Opioid / Q000378:metabolism*
D006146:Guanidines; D010648:Phenylacetates; D011957:Receptors, Opioid; D004174:Diprenorphine; D016316:Guanfacine; D005048:Etorphine; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; D000242:Cyclic AMP; D000135:Acid Phosphatase